GlassScriptPhysician profile
Dipan Uppal
NPI 1568948081
$5,145.22
in general payments reported to CMS, 2019-2025
11 companies · $598 in 2025
The $598 reported for 2025 was less than what a typical Advanced Heart Failure and Transplant Cardiology provider received nationally (typical 2025 total: $1,046).
See the full distribution for Advanced Heart Failure and Transplant Cardiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $190 · 2022: $141 · 2023: $653 · 2024: $3,564 · 2025: $598.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,150 · Travel and Lodging: $2,041.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,150.04 |
| Travel and Lodging | $2,040.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,019.37 | 2024-2025 | Cardiomems, Gallant, Thoratec Heartmate 3 Lvas Implant Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $203.17 | 2022-2024 | Jardiance |
| Cvrx, INC. | $186.25 | 2025 | Barostim Neo System |
| Shockwave Medical, INC | $183.85 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Edwards Lifesciences Corporation | $181.08 | 2024 | |
| Medtronic, INC. | $154.05 | 2024 | Selectsecure, Azure Xt Dr Mri Surescan, Cobalt Dr Mri Surescan |
| Endotronix, INC. | $127.69 | 2025 | Cordella Pulomonary Artery Pressure Sensor |
| Astrazeneca Pharmaceuticals LP | $122.97 | 2024 | Lokelma |
| E.R. Squibb & Sons, L.L.C. | $64.02 | 2024 | Camzyos, Eliquis |
| Novartis Pharmaceuticals Corporation | $55.29 | 2024 | |
| Janssen Pharmaceuticals, INC | $34.71 | 2024 | Xarelto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dipan Uppal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.